Characterization of noradrenaline-induced increases in intracellular Ca2+ levels in Chinese hamster ovary cells stably expressing human alpha1A-adrenoceptor. 2007

Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
Department of Cellular Pharmacology, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.

The mechanism for noradrenaline (NA)-induced increases in intracellular Ca(2+) concentration ([Ca(2+)](i)) and physiological significance of Na(+) influx through receptor-operated channels (ROCs) and store-operated channels (SOCs) were studied in Chinese hamster ovary (CHO) cells stably expressing human alpha(1A)-adrenoceptor (alpha(1A)-AR). [Ca(2+)](i) was measured using the Ca(2+) indicator fura-2. NA (1 microM) elicited transient and subsequent sustained [Ca(2+)](i) increases, which were inhibited by YM-254890 (G(alphaq/11) inhibitor), U-73122 (phospholipase C (PLC) inhibitor), and bisindolylmaleimide I (protein kinase C (PKC) inhibitor), suggesting their dependence on G(alphaq/11)/PLC/PKC. Both phases were suppressed by extracellular Ca(2+) removal, SK&F 96365 (inhibitor of SOC and nonselective cation channel type-2 (NSCC-2)), LOE 908 (inhibitor of NSCC-1 and NSCC-2), and La(3+) (inhibitor of transient receptor potential canonical (TRPC) channel). Reduction of extracellular Na(+) and pretreatment with KB-R7943, a Na(+)/Ca(2+) exchanger (NCX) inhibitor, inhibited both phases of [Ca(2+)](i) increases. These results suggest that 1) stimulation of alpha(1A)-AR with NA elicits the transient and sustained increases in [Ca(2+)](i) mediated through NSCC-2 that belongs to a TRPC family; 2) Na(+) influx through these channels drives NCX in the reverse mode, causing Ca(2+) influx in exchange for Na(+) efflux; and 3) the G(alphaq/11)/PLC/PKC-dependent pathway plays an important role in the increases in [Ca(2+)](i).

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007424 Intracellular Fluid The fluid inside CELLS. Fluid, Intracellular,Fluids, Intracellular,Intracellular Fluids
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007811 Lanthanum The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass.
D008301 Maleimides Derivatives of maleimide (the structural formula H2C2(CO)2NH) containing a pyrroledione ring where the hydrogen atom of the NH group is replaced with aliphatic or aromatic groups.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular

Related Publications

Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
June 1999, British journal of pharmacology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
September 1994, European journal of pharmacology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
May 1997, The Journal of general physiology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
March 2004, Biochemical pharmacology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
August 1998, Journal of molecular endocrinology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
May 2001, International immunopharmacology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
July 1994, British journal of pharmacology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
December 1998, British journal of pharmacology,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
November 1996, Pharmaceutical research,
Takahiro Horinouchi, and Yumie Miyake, and Tadashi Nishiya, and Arata Nishimoto, and Shoko Yorozu, and Atsushi Jinno, and Emi Kajita, and Soichi Miwa
January 1993, The Journal of biological chemistry,
Copied contents to your clipboard!